* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:MRVI vs ANRO, BBOT, REPL: FCF Margin % Comparison
For the Biotechnology subindustry, Maravai LifeSciences Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Maravai LifeSciences Holdings FCF Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Maravai LifeSciences Holdings's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Maravai LifeSciences Holdings's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Maravai LifeSciences Holdings (MEX:MRVI) has a FCF Margin % of 6.42% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Maravai LifeSciences Holdings and its competitors. This is 50% below median its historical median of 12.94. According to the industry distribution chart, Maravai LifeSciences Holdings ranks #368 out of 959 companies in the Biotechnology industry, placing it in the top 38.4%.
Is Maravai LifeSciences Holdings' FCF Margin % too high?
Maravai LifeSciences Holdings' current FCF Margin % of 6.42% is 50% below median its 10-year median of 12.94. Based on the distribution chart, Maravai LifeSciences Holdings ranks #368 out of 959 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Maravai LifeSciences Holdings has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Maravai LifeSciences Holdings' FCF Margin % compare to ANRO and BBOT?
According to the Biotechnology industry distribution chart, Maravai LifeSciences Holdings ranks #368 out of 959 companies for FCF Margin %. This puts Maravai LifeSciences Holdings in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Maravai LifeSciences Holdings and its competitors. Maravai LifeSciences Holdings's current FCF Margin % is 6.42%, which is 50% below median its own 10-year median of 12.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maravai LifeSciences Holdings stock overvalued right now?
Maravai LifeSciences Holdings (MEX:MRVI) has a current FCF Margin % of 6.42%. The stock's GF Value™ is MXN53.06, compared to a current price of MXN85.00 — trading 60.2% above its estimated fair value. The current FCF Margin % is 6.42%, which is 50% below median its 10-year median of 12.94. Maravai LifeSciences Holdings' overall GF Score™ is 62/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Maravai LifeSciences Holdings (MEX:MRVI), the current FCF Margin % is 6.42% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Maravai LifeSciences Holdings (MEX:MRVI) Overvalued in 2026?
Based on GuruFocus' analysis, Maravai LifeSciences Holdings stock appears to be overvalued.
The current stock price of MXN85.00 is trading 60.2% above its estimated GF Value™ of MXN53.06.
Key valuation signals for MEX:MRVI:
FCF Margin %: 6.42% (50% below median its 10-year median of 12.94)
GF Value™: MXN53.06 vs. price of MXN85.00 (60.2% above fair value)
No single metric tells the full story. See the MEX:MRVI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Maravai LifeSciences Holdings Business Description
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.
62GF Score
Get the complete analysis for MEX:MRVI
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:MRVI has been successfully added to your 
